T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING PROTEIN 3 (TIM-3) INHIBITORS IN ONCOLOGY CLINICAL TRIALS: A REVIEW

T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review

ABSTRACT: T cell immunoglobulin and mucin domain containing protein 3 (TIM-3) is a receptor found on a multitude of immune cells and is commonly overexpressed in patients with cancer.Due to its Patient Alarms selective expression in immune cells and its preliminary efficacy in preclinical models, TIM-3 is a promising target Keypad Assembly as a tre

read more


Clearance of materials from accelerator facilities

A new Technical Standard that supports the clearance of materials and equipment (personal property) from U.S.Department of Energy (DOE) accelerator facilities has been developed.The Standard focuses on personal property that has the potential to be radiologically impacted by accelerator operations.It addresses material clearance programs and protoc

read more

Results of an open multicenter study of theefficiency of one-week antihelicobacter therapy using omeprazole, clarithromycin, and amoxycillin in patients withduodenal peptic ulcer

Aim.To study the efficiency of one-week antihelicobacter therapy using omeprazole, clarithromycin, and amoxycillin in patients with duodenal peptic ulcer during its recurrence.Materials and Patient Alarms methods.105 patients with recurrent peptic ulcer and a not less than 0.5-cm ulcer in the duodenal bulb was given triple therapy: omeprazole, 20 m

read more